Cumberland Pharmaceuticals Inc.
CPIX
$5.72
-$0.14-2.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -361.68% | 25.85% | -25.69% | 31.77% | 164.59% |
| Total Depreciation and Amortization | 18.58% | -25.51% | -5.58% | -7.41% | -8.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.68% | 129.57% | 99.51% | 106.83% | 184.35% |
| Change in Net Operating Assets | 77.03% | -101.25% | -39.26% | 124.00% | 180.96% |
| Cash from Operations | -90.07% | -99.84% | -60.63% | 198.61% | 282.46% |
| Capital Expenditure | -- | 100.00% | -54.55% | -268.06% | -14.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.82% | -12,444.08% | -425.37% | 888.89% | -7,012.05% |
| Cash from Investing | 95.02% | -11,367.54% | -464.35% | 710.90% | -2,010.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | -30.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 75.19% | 100.00% | 89.47% | 94.63% | 0.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.41% | -46.73% | 14.06% | 21.44% | 18.96% |
| Cash from Financing | 86.19% | 50.54% | 27.92% | 51.29% | -328.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.68% | -851.32% | -794.08% | 180.77% | -1,358.62% |